MFANHIGH SIGNALFINANCIAL10-K

MFAN experienced a dramatic collapse in capital expenditures alongside substantially reduced operating cash flow despite higher net income, creating significant cash flow stress.

The near-total elimination of capital expenditures suggests either severe cash constraints or a fundamental shift in business strategy that could impact long-term competitiveness. The sharp decline in operating cash flow combined with meaningfully higher interest expenses indicates potential liquidity pressures and increased financial leverage that warrant close monitoring.

Comparing 2026-02-20 vs 2025-02-20View on EDGAR →
FINANCIAL ANALYSIS

MFAN's financial position shows concerning stress signals with operating cash flow declining substantially while interest expenses grew meaningfully, reflecting increased debt burden. Despite higher net income, the company's cash position weakened and total liabilities expanded significantly faster than assets. The dramatic reduction in capital expenditures to minimal levels suggests either severe cash preservation efforts or a major strategic pivot that could impact future growth capacity.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
-97.5%
$12.0M$300K

Capex reduced 97.5% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Interest Expense
P&L
+65.8%
$258.8M$429.1M

Interest expense surged 65.8% — significant debt increase or rising rates materially impacting earnings.

Operating Cash Flow
Cash Flow
-61.9%
$200.1M$76.2M

Operating cash flow fell 61.9% — earnings quality concerns; investigate working capital changes and non-cash items.

Net Income
P&L
+48.2%
$119.3M$176.8M

Net income grew 48.2% — bottom-line growth signals improving overall business health.

Cash & Equivalents
Balance Sheet
-37.1%
$338.9M$213.2M

Cash declined 37.1% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Total Liabilities
Balance Sheet
+17.3%
$9.6B$11.2B

Liabilities increased 17.3% — monitor debt-to-equity ratio and interest coverage.

Total Assets
Balance Sheet
+14.3%
$11.4B$13.0B

Asset base grew 14.3% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2026-02-20
PRIOR — 2025-02-20
ADDED
On February 17, 2026, the registrant had a total of 102,093,862 shares of Common Stock outstanding.
Changes in and Disagreements W ith Accountants on Accounting and Financial Disclosure 125 Report of Independent Registered Public Accounting Firm 66 Consolidated Balance Sheets at December 31, 202 5 and December 31, 202 4 68 Item 9A.
Other Information 127 Consolidated Statements of Operations for the years ended December 31, 202 5 , 202 4 and 202 3 69 Item 9C.
Executive Compensation 127 Consolidated Statements of Changes in Stockholders Equity for the years ended December 31, 202 5 , 202 4 and 202 3 71 Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 128 Consolidated Statements of Cash Flows for the years ended December 31, 202 5 , 202 4 and 202 3 73 Item 13.
+7 more — sign up free →
REMOVED
On February 14, 2025, the registrant had a total of 102,523,820 shares of Common Stock outstanding.
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 126 Report of Independent Registered Public Accounting Firm 66 Financial Statements: Item 9A.
Controls and Procedures 126 Consolidated Balance Sheets at December 31, 2024 and December 31, 2023 68 Item 9B.
Directors, Executive Officers and Corporate Governance 128 Consolidated Statements of Comprehensive Income/(Loss) for the years ended December 31, 2024, 2023 and 2022 70 Item 11.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 129 Consolidated Statements of Changes in Stockholders Equity for the years ended December 31, 2024, 2023 and 2022 71 Item 13.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →